Literature DB >> 6250861

Effects of cholecystokinin-like peptides on rearing activity and hexobarbital-induced sleep.

G Zetler.   

Abstract

Caerulein and the C-terminal octapeptide of cholecystokinin (CCK-8), when subcutaneously injected into mice, inhibited spontaneous rearing activity and prolonged the hexobarbotal sleeping time. These effects were resistant to naloxone. In molar terms, caerulein was 40 times (hexobarbital potentiation) or 115 times (rearing) more potent than diazepam. CCK-8 was less active than caerulein) though still superior to diazepam.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6250861     DOI: 10.1016/0014-2999(80)90307-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment.

Authors:  J Harro; M Põld; E Vasar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

2.  Infusions of cholecystokinin octapeptide into the ventral tegmental area potentiate amphetamine conditioned place preferences.

Authors:  H O Pettit; K Mueller
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Effects of ceruletide on the dopamine receptor-adenylate cyclase system in striatum and frontal cortex of rats chronically treated with haloperidol.

Authors:  Y Hatta; S Hatta; T Saito
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Effects of ceruletide on perioral movements and the dopamine receptor-adenylate cyclase system in rats chronically treated with fluphenazine.

Authors:  T Ashizawa; T Saito; N Takahata
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

5.  Caerulein and morphine in a model of visceral pain. Effects on the hypotensive response to renal pelvis distension in the rat.

Authors:  H Brasch; G Zetler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-05       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.